摘要
目的:观察复方丹参滴丸治疗稳定型心绞痛(SAP)患者4周后血清基质金属蛋白酶-9(MMP-9) 和肿瘤坏死因子α(TNF-α)的变化,以了解复方丹参滴丸治疗对斑块稳定性的影响。方法:60例SAP 患者被分为复方丹参滴丸治疗组和常规治疗组,测定治疗前后MMP-9和TNF-α水平。结果:复方丹参滴丸治疗组MMP-9和TNF-α水平较治疗前及对照组明显降低(P 均<0. 01) 。结论:复方丹参滴丸治疗可明显降低稳定型心绞痛患者炎症因子MMP- 9和TNF-α水平,有利于稳定动脉粥样硬化斑块。
Objective: To observe the effects of complex prescription danshen root drop pill (CDD) on matrix matalloproteinase-9 (MMP-9) and tumor necrosis faetor-α (TNF-α) levels in patients with stable angina peetoris (SAP).Methods: Sixty SAP patients were randomly divided into either the CDD group (observe group) or the control group.The levels of MMP-9 and TNF-α before and after treatment were detected. Results: After treatment, the levels of MMP-9 and TNF-α in CDD group significantly decreased compared with levels before treatment and those of controlgroup (P〈0.01 all), Conclusion: Complex prescription danshen root drop pill treatment can decrease levels of inflammatory factors such as MMP-9 and TNF-α in patients with stable angina peetoris, so it may benefit to atherosclerotic plaque stabilization.
出处
《心血管康复医学杂志》
CAS
2005年第4期319-321,共3页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
基质金属蛋白酶类
肿瘤坏死因子-Α
复方丹参
Matrix matalloproteinase
Tumor necrosis factor-α
Complex prescription danshen root